Subject: Treatment & Procedure

Botulinum toxin type a therapy

Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage ​ Synopsis: ​ Hidradenitis suppurativa is a […]

Topical, systemic and biologic therapies in HS

Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms ​ Synopsis: ​ Hidradenitis suppurativa (HS) is a chronic inflammatory disease of the skin, manifesting in […]

Intralesional corticosteroid injection for the treatment of HS

Synopsis: ​ Background and objectives: Hidradenitis suppurativa (HS) is a chronic inflammatory disease of the follicular unit characterized by recurrent, painful, skin lesions including inflammatory nodules, abscesses, tunnels, and mutilating […]

Dapsone therapy for hidradenitis suppurativa: a series of 24 patients

Synopsis: ​ Background: Hidradenitis suppurativa (HS) is an inflammatory skin disease with a chronic intermittent course. HS is difficult to treat, and the evidence for the effect of most treatments […]

Botulinum Toxin Off-Label Use in Dermatology

Botulinum Toxin Off-Label Use in Dermatology: A Review *hidradenitis suppurativa cited in this research. ​ Synopsis: ​ Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum which causes […]

Cryoinsufflation for Hurley Stage II

A woman in her 30s presented with hidradenitis suppurativa (HS), Hurley stage II. She was treated with oral contraceptives (drospirenone/ethinyl estradiol), spironolactone (50 mg/d), topical clindamycin, and monthly intralesional corticosteroids […]

1 2 3